HealthcareAug 11, 2026

Lonza Group AG

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

1896-12-31

15,375 Employees

Industry

Healthcare

Services

Lonza Group AG Overview

Company Headquarters: Basel, Switzerland

Founded: 1897

Workforce: ~15,375

Company Working: Lonza is engaged in the manufacturing and supply of oilfield biocides as well as pharmaceutical, healthcare, and life science products. It operates through the pharma & biotech, specialty ingredients, and corporate segments. The specialty ingredients segment consists of two divisions, consumer health and consumer resources and protection. The pharma & biotech segment comprises the development and manufacturing of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources.

Strategy

Lonza focusses on being a leading integrated, value-adding solutions provider for the healthcare Continuum. It is also focusing on providing breakthrough technologies fundamentally impacting and improving drug discovery, drug development, and biopharmaceutical manufacturing. Investments in research & development are a significant part of the company’s operation, which helps the company to gain a competitive advantage over other players.

Company Snapshot

$4,332.2M

Revenue

15,375

Employees

1896-12-31

Founded

Basel, Switzerland

Headquarters

SWOT Analysis

Strengths

The company has a global presence with its operations spread across Asia, Europe, the Americas, and other countries
Strong distribution network worldwide
Brand name
Dominance in the domestic market
Strong product portfolio

Weaknesses

Large dependency on the American markets for revenue generation
In adequate supply chain

Opportunities

Strategic arrangements with other companies to enhance its product portfolio
Global penetration through mergers and acquisitions
Growth initiatives such as expansion, new product launches, and acquisitions

Threats

Increasing competition from other companies in developing markets
Revenue vulnerable to exchange rate fluctuations
Fluctuating raw material prices

Key Developments

Date	Approach	Development
05 April 2016	Launch	The company added innovative in can preservative to their biocides brand named proxel range This range was launched to address the challenging global regulatory requirement of the industry. The product is dual-active, broad-spectrum biocide for wet-state preservation of water-based paints, adhesives and construction chemicals. The product is free of formaldehyde and VOC and is pH and temperature stable. It benefits from the use of two complementary active ingredients providing an enhanced antimicrobial efficacy and protection from bacteria, yeasts, and molds in a wide range of industrial applications.
December 2020	Agreement	Lonza announced a license agreement with Arbor Biotechnologies (US). As per the agreement Lonza with retrieve to Arbor's gene editing technology. Lonza has the capability to use Arbor's proprietary technology in its bioproduction products and services.

Product Offering

Lonza Group AG
- Global Oilfield Biocides Market
- Gene Editing

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD49/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Lonza Group AG as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Lonza Group AG

Company Headquarters: Basel, Switzerland Founded: 1897 Workforce: ~15,375 Company Working: Lonza is engaged in the manufacturing and supply of oilfield biocides as well as pharmaceutical, healthcare, and life science products. It operates through the pharma & biotech, specialty ingredients, and corporate segments. The specialty ingredients segment consists of two divisions, consumer health and consumer resources and protection. The pharma & biotech segment comprises the development and manufacturing of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources.

Starting from

$4,950